A National Review of State Laws for Stock Epinephrine in Schools
Supporting Files
-
2 2022
-
File Language:
English
Details
-
Alternative Title:J Sch Health
-
Personal Author:
-
Description:BACKGROUND:
Anaphylaxis is a life-threatening allergic reaction with significant risk for children with allergies. Access to potentially life-saving medication is critical for these children. This review aims to describe state laws and policies guiding stock epinephrine in schools for allergic or anaphylactic events and detail recommendations for best practices.
METHODS:
This paper is a comprehensive review of the 50 states and District of Columbia’s (DC) laws and policies for stock epinephrine at schools for children in pre-kindergarten through 12th grade.
RESULTS:
All 50 states and DC allow undesignated epinephrine in schools to use for allergic or anaphylactic reactions. A key difference arises in whether states allow (N=37) or mandate (N=14) that schools stock epinephrine. States exhibit differences in the body responsible for developing stock epinephrine policy (N=48), along with stakeholders responsible for developing procedures (N=30) and implementing them (N=19). Differences also exist in state epinephrine procurement, administration, training, and liability.
CONCLUSIONS:
This review of stock epinephrine laws and policies highlights the significant variation in state legislation despite widespread adoption. Only one-quarter of states mandate that schools have stock epinephrine available for emergency use, underscoring need for a more unified approach with consistent guidelines, comprehensive training, and possible funding for implementation.
-
Subjects:
-
Source:J Sch Health. 92(2):209-222
-
Pubmed ID:34825371
-
Pubmed Central ID:PMC8884139
-
Document Type:
-
Funding:
-
Volume:92
-
Issue:2
-
Collection(s):
-
Main Document Checksum:urn:sha256:5221123118772f7252b6d1ad4f9068e6e78925c7db1ed39c8800a6c8c6a97b50
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access